Cefazedone: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk mNo edit summary |
imported>David E. Volk m (IUPAC name) |
||
Line 12: | Line 12: | ||
|properties=beta-lactam | |properties=beta-lactam | ||
|hazards=see drug interactions | |hazards=see drug interactions | ||
|iupac= | |iupac= <nowiki>(6R-trans)-7-(((3,5-dichloro-4-oxo-1(4H)-pyridinyl) acetyl) amino)-3-(((5-methyl-1,3,4- thiadiazol- 2-yl)thio) methyl)-8 -oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid</nowiki> | ||
|casnumber= 56187-47-4 | |casnumber= 56187-47-4 | ||
}} | }} |
Revision as of 09:42, 29 April 2008
| |||||||
cefazedone | |||||||
| |||||||
Uses: | antibiotic | ||||||
Properties: | beta-lactam | ||||||
Hazards: | see drug interactions | ||||||
|
Cefazedone is a cephalosporin type of antibiotic drug used to treat bacterial infections. Like other cephalosporins, penicillins and some other antibiotics, it functions due to the presence of the beta-lactam in the structure.